BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5287011)

  • 1. [Use of rubomycin C in acute leukemia and blastic exacerbation of chronic myeloleukemia].
    Isaev VG; Bartashchuk EI; Kovaleva LG; Mokeeva RA
    Probl Gematol Pereliv Krovi; 1971 Mar; 16(3):34-40. PubMed ID: 5287011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of intensive cytostatic treatment of blastic exacerbation of chronic myeloid leukemia].
    Sylwestrowicz T; Zdziechowska H; Maj S; Pawelski S; Lewicka T
    Pol Tyg Lek; 1978 Apr; 33(15):583-6. PubMed ID: 274692
    [No Abstract]   [Full Text] [Related]  

  • 3. Blastic crisis of chronic myelogenous leukaemia.
    Koza I; Cerný V; Bohunický L; Hal'ko J; Ujházy V; Petrek C; Krizan Z
    Neoplasma; 1969; 16(4):417-26. PubMed ID: 5259327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myelobromol and its use in the treatment of chronic myeloleukemia].
    Shil'nikov VV; Razheva VP
    Ter Arkh; 1971 May; 43(5):22-6. PubMed ID: 5286867
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of levamisole for preventing infectious complications in chronic myeloleukemia in the stage of blast exacerbation].
    Stakovetskaia ZS
    Vrach Delo; 1987 Aug; (8):48-50. PubMed ID: 3479862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of acute leukemia in adults. 7-year case material from the Tromsø Regional Hospital].
    Hannisdal E; Grøttum KA
    Tidsskr Nor Laegeforen; 1983 Feb; 103(4):287-90. PubMed ID: 6344319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment characteristics in chronic myeloleukemia].
    Abdulkadyrov KM; Kuzmenko EL; Shcherbakova EG
    Sov Med; 1979 Aug; (8):22-7. PubMed ID: 293053
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
    Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
    Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytologic characteristics of blastic crisis in chronic myeloleukemia].
    Terent'eva EI; Korenevskaia MI; Kozinets GI; Mokeeva RA; Dul'tsina SM
    Probl Gematol Pereliv Krovi; 1971 Jul; 16(7):16-23. PubMed ID: 5288234
    [No Abstract]   [Full Text] [Related]  

  • 12. [High risk febrile neutropenia in acute leukemia. The experience of a public hospital. National Program of Antineoplastic Drugs in Adult, Hospital del Salvador, 1991-2001].
    Puga B; Puga I; Cabrera ME; Undurraga MS; Guerra C; Urrejola G; Toro P
    Rev Med Chil; 2003 Sep; 131(9):1023-30. PubMed ID: 14635589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy for chronic leukemia].
    Kitajima K; Takahashi I; Fujimoto S
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1895-902. PubMed ID: 6964033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriological investigations on patients with acute leukemia under protective environment (author's transl)].
    Nagao T; Katanabe K; Komatsuda M; Arimori S
    Rinsho Ketsueki; 1979 Jan; 20(1):8-14. PubMed ID: 423377
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences with the treatment of acute leukemias and blast crises in chronic myeloproliferative diseases].
    Eggeling T; Braumann D; Mainzer K
    Med Welt; 1981 Jul; 32(27):1077-80. PubMed ID: 6943405
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
    Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of research results with bone marrow trephine biopsy material in chronic myeloleukemia].
    Shardakov VI; Machul'skiĭ LM
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):45-8. PubMed ID: 6946415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of terminal exacerbations of chronic myeloleukemia].
    Mokeeva RA
    Probl Gematol Pereliv Krovi; 1965 Sep; 10(9):39-45. PubMed ID: 5222531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.